To assess current trends in urothelial cancer research and evaluate opportunities to make best use of successful drug development, Matthew D. Galsky, MD, assistant professor of urology at The Mount Sinai Hospital, and colleagues performed a search of the ClinicalTrials.gov registry for clinical trials designed to explore interventions in muscle-invasive and metastatic urothelial cancer. "Barriers such as insufficient funding and accrual concerns have driven patient resources into small, nonrandomized, single-center trials that are generally not designed, nor intended, to immediately advance current care standards," Galsky and colleagues wrote. Learn more